School of Medicine
Showing 1-10 of 16 Results
Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital
Current Research and Scholarly Interests Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
Associate Professor of Radiology (General Radiology)
Current Research and Scholarly Interests As a physician-scientist involved in the care of patients and investigating novel "cellular imaging" technologies, my goal is to develop innovative, non-invasive, clinically applicable imaging solutions to significant problems in disease diagnosis. My research team works on novel "cellular imaging" techniques for improved detection and characterization of malignant tumors, for the diagnosis of immune system disorders and for in vivo evaluation of stem cell transplants.
Edward J. Damrose, MD, FACS
Associate Professor of Otolaryngology - Head and Neck Surgery at the Stanford University Medical Center
Current Research and Scholarly Interests Advanced MRI imaging for laryngeal cancer and swallowing disorders; applications of robotics in microlaryngeal surgery; high speed digital imaging of vocal fold vibration; the effects of hormones and anabolic steroids on vocal function.
Professor of Radiology (General Radiology) and, by courtesy, of Bioengineering
Current Research and Scholarly Interests 1. MRI of Breast Cancer, particularly new techniques. Currently being explored are techniques including ultra high spatial resolution MRI and contrast-agent-free detection of breast tumors.
2. MRI-guided interventions, especially MRI-guided cryosurgery of prostate cancer
Mark M. Davis
The Burt and Marion Avery Family Professor
Current Research and Scholarly Interests Molecular mechanisms of lymphocyte recognition and differentiation; Systems immunology and human immunology; vaccination and infection.
Ronald W. Davis
Professor of Biochemistry and of Genetics
Current Research and Scholarly Interests We are using Saccharomyces cerevisiae and Human to conduct whole genome analysis projects. The yeast genome sequence has approximately 6,000 genes. We have made a set of haploid and diploid strains (21,000) containing a complete deletion of each gene. In order to facilitate whole genome analysis each deletion is molecularly tagged with a unique 20-mer DNA sequence. This sequence acts as a molecular bar code and makes it easy to identify the presence of each deletion.
Associate Professor (Research) of Medicine (Quantitative Sciences Unit) and, by courtesy, of Health Research and Policy
Current Research and Scholarly Interests Dr. Desai is the Director of the Quantitative Sciences Unit. She is interested in the application of biostatistical methods to all areas of medicine including oncology, nephrology, and endocrinology. She works on methods for the analysis of epidemiologic studies, clinical trials, and studies with missing observations.
Assistant Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly Interests Development and maintenance of alveolar epithelium; alveolar morphogenesis and repair; lung adenocarcinoma cell type of origin
Associate Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly Interests Although stress has a bad reputation the fight-or-flight stress response is nature's fundamental survival system. Our laboratory elucidates mechanisms that mediate the newly appreciated immunoenhancing effects of short-term stress versus the well known immunosuppressive effects of long-term stress. We investigate stress effects on leukocyte trafficking, cytokine gene/protein expression, and innate/adaptive immunity, in preclinical & clinical models of skin immunity, vaccines, surgery, & cancer.
Maximilian Diehn, MD, PhD
Assistant Professor of Radiation Oncology
Current Research and Scholarly Interests My laboratory focuses on two main areas: 1) cancer stem cell biology and 2) novel biomarkers for identifying the presence of malignant cells (diagnostic), predicting outcome (prognostic), and predicting response to therapy (predictive). Areas of study include cancers of the lung, breast, and gastrointestinal system. Clinically I specialize in the treatment of lung cancer and applications of stereotactic ablative radiotherapy and perform both prospective and retrospective clinical studies.